We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+8.98%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$14.5B
AUM Growth
+$1.83B
(+14%)
Cap. Flow
+$876M
Cap. Flow
% of AUM
6.02%
Top 10 Holdings %
Top 10 Hldgs %
16.47%
Holding
2,314
New
674
Increased
480
Reduced
478
Closed
662
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PayPal
PYPL
|
+$137M |
| 2 |
Home Depot
HD
|
+$120M |
| 3 |
Amazon
AMZN
|
+$96.2M |
| 4 |
eBay
EBAY
|
+$85.4M |
| 5 |
Agilent Technologies
A
|
+$79.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
McDonald's
MCD
|
+$107M |
| 2 |
Danaher
DHR
|
+$78M |
| 3 |
Thermo Fisher Scientific
TMO
|
+$71M |
| 4 |
Yum! Brands
YUM
|
+$61.4M |
| 5 |
CELG
Celgene Corp
CELG
|
+$57.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.89% |
| 2 | Consumer Discretionary | 20.94% |
| 3 | Technology | 12.55% |
| 4 | Financials | 6.81% |
| 5 | Industrials | 6.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1401
CRISPR Therapeutics
CRSP
$4.58B
| $145K | ﹤0.01% |
+2,374
| New | +$130K |
|
1402
CAE Inc. Common Shares
CAE
$8.1B
| $142K | ﹤0.01% |
+5,346
| New | +$138K |
|
1403
MediciNova
MNOV
$65M
| $142K | ﹤0.01% |
+21,092
| New | +$159K |
|
1404
Enovis
ENOV
$1.56B
| $139K | ﹤0.01% |
+2,224
| New | +$126K |
|
1405
Suncor Energy
SU
$77.7B
| $138K | ﹤0.01% |
4,196
-587,548
| -99% | -$18.3M |
|
|
TNAV
1406
DELISTED
Telenav Inc.
TNAV
| $138K | ﹤0.01% |
+28,427
| New | +$138K |
|
1407
Asure Software
ASUR
$220M
| $137K | ﹤0.01% |
16,776
+249
| +2% | +$2.08K |
|
1408
TechnipFMC
FTI
$30.6B
| $136K | ﹤0.01% |
8,502
-424,792
| -98% | -$6.59M |
|
|
PFNX
1409
DELISTED
Pfenex Inc.
PFNX
| $135K | ﹤0.01% |
12,262
-50,176
| -80% | -$498K |
|
1410
Global Net Lease
GNL
$1.87B
| $134K | ﹤0.01% |
6,628
-880,383
| -99% | -$17.4M |
|
1411
Danaos Corp
DAC
$2.55B
| $132K | ﹤0.01% |
+14,359
| New | +$139K |
|
|
HTZ
1412
DELISTED
Hertz Global Holdings, Inc.
HTZ
| $132K | ﹤0.01% |
8,381
-92,233
| -92% | -$1.38M |
|
1413
M/I Homes
MHO
$3.83B
| $131K | ﹤0.01% |
3,319
-24,034
| -88% | -$1.01M |
|
|
NWHM
1414
DELISTED
THE NEW HOME COMPANY INC.
NWHM
| $131K | ﹤0.01% |
28,155
-8,085
| -22% | -$36.8K |
|
1415
Equinor
EQNR
$95.9B
| $128K | ﹤0.01% |
6,435
+4,401
| +216% | +$83.3K |
|
1416
Intrepid Potash
IPI
$460M
| $126K | ﹤0.01% |
4,651
-57,116
| -92% | -$1.55M |
|
1417
Kinder Morgan
KMI
$73.1B
| $126K | ﹤0.01% |
+5,929
| New | +$120K |
|
|
PDCE
1418
DELISTED
PDC Energy, Inc.
PDCE
| $126K | ﹤0.01% |
+4,818
| New | +$116K |
|
1419
CEMIG Preferred Shares
CIG
$6.09B
| $124K | ﹤0.01% |
+71,096
| New | +$116K |
|
1420
Madrigal Pharmaceuticals
MDGL
$12.6B
| $123K | ﹤0.01% |
1,350
-686
| -34% | -$66.5K |
|
1421
iShares US Consumer Discretionary ETF
IYC
$1.12B
| $122K | ﹤0.01% |
+2,144
| New | +$119K |
|
1422
Constellium
CSTM
$3.96B
| $121K | ﹤0.01% |
9,053
+6,840
| +309% | +$94.4K |
|
|
XIN
1423
DELISTED
Xinyuan Real Estate
XIN
| $120K | ﹤0.01% |
+3,155
| New | +$124K |
|
|
SBE.WS
1424
DELISTED
Switchback Energy Acquisition Corporation Warrants, exercisable for one share of Class A Common Stoc
SBE.WS
| $120K | ﹤0.01% |
+199,998
| New | +$145K |
|
1425
Phillips 66
PSX
$82.9B
| $119K | ﹤0.01% |
+1,066
| New | +$120K |
|
Similar funds
Marshall Wace's Q4 2019 Portfolio in Review
As of Q4 2019, Marshall Wace held 2,314 positions worth $14.5B, up 14% from $12.7B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Marshall Wace deployed $876M of net new capital in Q4 2019, opening 674 new positions and adding to 480 existing holdings. Its largest new stake was Procter & Gamble: 356,181 shares worth $44.5M.
By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 25% a quarter earlier, followed by Consumer Discretionary and Technology.
On the sell side, the largest reduction was McDonald's, an estimated $107M trimmed.
- Marshall Wace's largest Q4 2019 buy was Procter & Gamble: 356,181 shares worth $44.5M.
- Marshall Wace added most to PayPal in Q4 2019, an estimated $137M increase.
- Marshall Wace's biggest Q4 2019 reduction was McDonald's, cutting an estimated $107M.
- Marshall Wace fully exited Yum! Brands in Q4 2019, selling an estimated $61.4M.
- Marshall Wace's ten largest holdings make up 16% of its $14.5B portfolio in Q4 2019.
- Marshall Wace opened 674 new positions and closed 662 in Q4 2019.
- Marshall Wace's portfolio value rose 14% quarter-over-quarter to $14.5B.
Based on Marshall Wace's 13F filing for Q4 2019, filed 14 Feb 2020.